Prevalence and Contributing Factors of Isoniazid Monoresistance and Multidrug-Resistant Tuberculosis in Almaty, Kazakhstan - Scorecard - MDSpire

Prevalence and Contributing Factors of Isoniazid Monoresistance and Multidrug-Resistant Tuberculosis in Almaty, Kazakhstan

  • By

  • Juliana G. E. Bartels

  • Nurlan Takenov

  • Lyailya Chingissova

  • Anar Rakisheva

  • Ainur Eleusizova

  • Venera Bismilda

  • Lyazzat Yeraliyeva

  • Yanis Ben Amor

  • January 29, 2026

  • 0 min

Share

Clinical Scorecard: Prevalence and Contributing Factors of Isoniazid Monoresistance and Multidrug-Resistant Tuberculosis in Almaty, Kazakhstan

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPresumptive TB cases over age 18 in Almaty, Kazakhstan, clearly defined.
Care Setting

Key Highlights

  • 1.1 million INH-resistant TB cases

Guideline-Based Recommendations

Diagnosis

    Management

    • A
    • d
    • d
    • s
    • p
    • e
    • c
    • i
    • f
    • i
    • c
    • m
    • a
    • n
    • a
    • g
    • e
    • m
    • e
    • n
    • t
    • g
    • u
    • i
    • d
    • e
    • l
    • i
    • n
    • e
    • s
    • f
    • o
    • r
    • H
    • r
    • -
    • T
    • B
    • .

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        Include treatment regimens for confirmed resistance.

        Clinical Best Practices

        • implement_new_second-line_treatment_regimens

        References

        Original Source(s)

        Related Content